KALIL CHARLES J 4

4 · DowDuPont Inc. · Filed May 24, 2018

Form 4

Period: 2018-05-22

Special CounsellorOther

Transactions

Sale
Common Stock
2018-05-22$68.41/sh−91,035$6,227,613→ 306,848.742 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2018-05-22−38,813→ 10,231 total
Exercise: $34.00Exp: 2022-02-10→ Common Stock (38,813 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2018-05-22−91,035→ 110,255 total
Exercise: $32.16Exp: 2023-02-15→ Common Stock (91,035 underlying)
Exercise/Conversion
Common Stock
2018-05-22$34.00/sh+38,813$1,319,642→ 436,696.742 total
Sale
Common Stock
2018-05-22$68.43/sh−38,813$2,656,012→ 397,883.742 total
Exercise/Conversion
Common Stock
2018-05-22$32.16/sh+91,035$2,927,686→ 397,883.742 total

Holdings

Footnotes (6)

[F1]The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F2]The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.66.
[F3]The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.72.
[F4]Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights.
[F5]The options vested in three annual installments beginning on February 10, 2013.
[F6]The options vested in three annual installments beginning on February 15, 2014.

Documents

1 file